BIO News Q2 results ...
Biotech sales reach $211,654 in Q2 2005
2005-10-31 05:40 ET - News Release
Mr. Robert Rieveley reports
SUCANON SALES SHOW QUARTERLY GROWTH
Biotech Holdings Ltd.'s sales in the company's second quarter ended Sept. 30, 2005, totalled $211,654, compared with sales of $123,411 in the quarter ended June 30, 2005. The figure reported for the June 30, 2005, period end comprised sales of $50,178 in the period Dec. 1, 2004, through March 31, 2005, which sales were moved into the June quarter to meet recognition guidelines, and sales of $73,233 from April 1, 2005, through June 30, 2005. The $211,654 figure for sales in the July-August-September period is 171 per cent of sales of $123,411 in the quarter ended June 30, 2005.
The accounts receivable balance as of Sept. 30, 2005, was $234,630 outstanding of total sales to Sept. 30, 2005, of $335,065. Total cash received from December, 2004, through Sept. 30, 2005, was $100,435, including $91,912 received in the three-month period to Sept. 30, 2005.
During the quarter, the company participated in trade shows both for the public, in Guadalajara and Monterrey (Mexico's second and third largest cities) and for the pharmaceutical trade in Mexico, specifically trade shows for pharmacies operated by two of the company's distributors, Marzam and Innova. During the quarter, national television distribution of Sucanon advertising continued, along with advertising on the nationally distributed radio show "Todo para la Mujer con Maxine Woodside." Information regarding tradeshow participation has previously been reported in news issued in Stockwatch dated July 14, 2005, information on television and radio advertising has previously been reported on May 27, 2005, and Sept. 23, 2005, and information on cash receipts has previously been reported in a news release of May 27, 2005, and of Aug. 5, 2005.
We seek Safe Harbor.